U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
194521194521Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic LeukemiaCompletedNo Results AvailableLeukemiaBiological: aldesleukin|Biological: filgrastim|Biological: therapeutic allogeneic lymphocytes|Drug: cytarabine|Drug: etoposide|Drug: fludarabine phosphate|Drug: methotrexate|Drug: mitoxantrone hydrochloride|Drug: therapeutic hydrocortisone|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00005802
194522194522Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaBiological: therapeutic allogeneic lymphocytes|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00005801
194523194523Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerCompletedNo Results AvailableBreast CancerBiological: Filgrastim|Drug: Docetaxel|Drug: Doxorubicin|Procedure: Surgeryhttps://ClinicalTrials.gov/show/NCT00005800
194524194524Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerActive, not recruitingNo Results AvailableAccelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute MyelDrug: fludarabine phosphate|Radiation: total-body irradiation|Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Biological: therapeutic allogeneic lymphocytes|Drug: cyclosporine|Drug: mycophenolate mofetil|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00005799
194525194525Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast CancerCompletedNo Results AvailableBreast CancerDrug: Carboplatin|Drug: Cyclophosphamide|Drug: Thiotepahttps://ClinicalTrials.gov/show/NCT00005798
194526194526Bone Marrow Transplant in Treating Patients With Hematologic CancersCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Multiple Myeloma and Malignant Plasma Cell Neoplasms|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsDrug: busulfan|Drug: Cyclophosphamide|Drug: VP-16|Radiation: Fractionated Total Body Irradiation (FTBI)https://ClinicalTrials.gov/show/NCT00005797
194527194527Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS TumorsCompletedNo Results AvailableBone Marrow Suppression|Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/OrganProcedure: filgrastim|Biological: gene therapy|Drug: lomustine|Drug: procarbazine hydrochloride|Drug: vincristine sulfate|Procedure: in vitro-treated peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00005796
194528194528Arsenic Trioxide in Treating Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00005795
194529194529Perifosine in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: perifosinehttps://ClinicalTrials.gov/show/NCT00005794
194530194530A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and EtoposideCompletedNo Results AvailableLeukemiaDrug: Cytarabine|Drug: Daunorubicin|Drug: Etoposide|Drug: Topotecanhttps://ClinicalTrials.gov/show/NCT00005793
194531194531Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaActive, not recruitingNo Results AvailableMultiple Myeloma|Plasma Cell NeoplasmDrug: etoposide phosphate|Drug: melphalan|Drug: topotecan|Procedure: Autologous Stem Cell Rescuehttps://ClinicalTrials.gov/show/NCT00005792
194532194532Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: cisplatin|Drug: fluorouracil|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00005791
194533194533Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWithdrawnNo Results AvailableBrain and Central Nervous System TumorsOther: laboratory biomarker analysis|Procedure: biopsy|Procedure: magnetic resonance imaging|Radiation: gadopentetate dimegluminehttps://ClinicalTrials.gov/show/NCT00005790
194534194534Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary SyndromeTerminatedNo Results AvailableLymphomaBiological: aldesleukinhttps://ClinicalTrials.gov/show/NCT00005788
194535194535Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNo Results AvailableLymphoma|NeutropeniaBiological: epoetin alfa|Biological: filgrastim|Biological: recombinant flt3 ligand|Biological: recombinant interleukin-3|Biological: sargramostim|Procedure: in vitro-treated peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00005787
194536194536Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or LeukemiaTerminatedNo Results AvailableExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Prolymphocytic Leukemia|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 FolliculaDrug: arsenic trioxide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00005786
194537194537Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood CancerCompletedNo Results AvailableHematologic Neoplasm|HIV InfectionDrug: GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RVhttps://ClinicalTrials.gov/show/NCT00005785
194538194538Evaluation and Treatment of Patients With Retinal DiseaseCompletedNo Results AvailableRetinal Diseasehttps://ClinicalTrials.gov/show/NCT00005784
194539194539A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling DisordersCompletedNo Results AvailableHemoglobin SC Disease|Sickle Cell AnemiaDrug: Recombinant-methionyl human stem cell factorhttps://ClinicalTrials.gov/show/NCT00005783
194540194540Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell TraitCompletedNo Results AvailableSickle Cell TraitDrug: Granulocyte colony-stimulating factor|Procedure: Leukapheresishttps://ClinicalTrials.gov/show/NCT00005782
194541194541Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual MolesCompletedNo Results AvailableDermatitis|Nevus|Psoriasishttps://ClinicalTrials.gov/show/NCT00005781
194542194542Chemotherapy Plus Vaccination to Treat Mantle Cell LymphomaActive, not recruitingNo Results AvailableMantle Cell Lymphoma|Lymphoma, Mantle CellDrug: EPOCH-R|Biological: GM-CSF|Drug: Idiotype vaccinehttps://ClinicalTrials.gov/show/NCT00005780
194543194543Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug TherapyCompletedNo Results AvailableHIV InfectionsDrug: Interleukin-12|Biological: HIV-1 C4-V3 Polyvalent Peptide Vaccinehttps://ClinicalTrials.gov/show/NCT00005779
194544194544High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV CyclophosphamideCompletedNo Results AvailableLupus Erythematosus, SystemicDrug: High-dose immunoablative therapyhttps://ClinicalTrials.gov/show/NCT00005778
194545194545Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)TerminatedNo Results AvailableBronchopulmonary Dysplasia|Respiratory Distress Syndrome|Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, PrematureProcedure: Minimal mechanical ventilation management|Procedure: Routine mechanical ventilation management|Drug: Dexamethasone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00005777
194546194546Inhaled Nitric Oxide Study for Respiratory Failure in NewbornsTerminatedNo Results AvailableInfant, Newborn|Hypertension, Pulmonary|Persistent Fetal Circulation Syndrome|Pneumonia, Aspiration|Respiratory Distress Syndrome, Newborn|Respiratory InsufficiencyDrug: Inhaled nitric oxide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00005776
194547194547Glutamine Supplementation to Prevent Death or Infection in Extremely Premature InfantsCompletedNo Results AvailableInfant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|SepsisDrug: Glutamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00005775
194548194548Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight InfantsTerminatedNo Results AvailableInfant, Newborn|Respiratory Distress Syndrome|Respiratory InsufficiencyDrug: Early surfactant|Drug: Standard practicehttps://ClinicalTrials.gov/show/NCT00005774
194549194549Early Inhaled Nitric Oxide for Respiratory Failure in NewbornsTerminatedNo Results AvailableInfant, Newborn|Hypertension, Pulmonary|Persistent Fetal Circulation Syndrome|Pneumonia, Aspiration|Respiratory Distress Syndrome, Newborn|Respiratory InsufficiencyDrug: Inhaled Nitric Oxide|Drug: Standard iNO therapyhttps://ClinicalTrials.gov/show/NCT00005773
194550194550Whole-Body Cooling for Birth Asphyxia in Term InfantsCompletedNo Results AvailableInfant, Newborn|Hypoxia-Ischemia, BrainDevice: Induced hypothermia|Device: Controlhttps://ClinicalTrials.gov/show/NCT00005772

* Görseller ve İçerik tekif hakkına sahip olabilir